Menu

European Pharmacopoeia (Ph. Eur.) Monograph 0478

The is the definitive general monograph governing the quality, production, and testing standards for Tablets within the European Union . Understanding this monograph is essential for pharmaceutical manufacturers to ensure batch-to-batch consistency and regulatory compliance. Core Requirements of Monograph 0478

Assay:

Every tablet sat within a tight 2% margin of the target dose.

If a tablet has a break-mark to allow for fractional dosing, the effectiveness of that break-mark must be validated:

0478

Monograph number is officially titled "Tablets." It is a general monograph, meaning it applies not to a specific drug (like paracetamol) but to the dosage form itself. It dictates the mandatory tests, procedures, and acceptance criteria that any tablet—whether immediate-release, effervescent, or orodispersible—must meet to be considered compliant within the EU.

These are critical performance tests.

Monograph 0478

defines tablets as "solid preparations each containing a single dose of one or more active substances." They are obtained by compressing uniform volumes of particles or by other methods of manufacture (e.g., moulding).